Insertion of the CXC chemokine ligand 9 (CXCL9) into the mouse hepatitis virus genome results in protection from viral-induced encephalitis and hepatitis
- 1 December 2008
- journal article
- Published by Elsevier BV in Virology
- Vol. 382 (2), 132-144
- https://doi.org/10.1016/j.virol.2008.09.032
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Evidence for Differential Roles for NKG2D Receptor Signaling in Innate Host Defense against Coronavirus-Induced Neurological and Liver DiseaseJournal of Virology, 2008
- Type I Interferons Are Essential in Controlling Neurotropic Coronavirus Infection Irrespective of Functional CD8 T CellsJournal of Virology, 2008
- CXCR3-Dependent Recruitment of Antigen-Specific T Lymphocytes to the Liver during Murine Cytomegalovirus InfectionJournal of Virology, 2007
- Role of STAT3 in Type I Interferon ResponsesPublished by Elsevier BV ,2006
- Coronavirus infection of the central nervous system: host–virus stand-offNature Reviews Microbiology, 2006
- CXC Chemokine Ligand 10 Controls Viral Infection in the Central Nervous System: Evidence for a Role in Innate Immune Response through Recruitment and Activation of Natural Killer CellsJournal of Virology, 2004
- Control of Central Nervous System Viral Persistence by Neutralizing AntibodyJournal of Virology, 2003
- A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defenseJCI Insight, 2000
- Murine coronavirus infection: a paradigm for virus-induced demyelinating diseaseTrends in Microbiology, 1997
- The ns 4 gene of mouse hepatitis virus (MHV), strain A 59 contains two ORFs and thus differs from ns 4 of the JHM and S strainsArchiv für die gesamte Virusforschung, 1993